Renaissance Technologies - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 54 filers reported holding EDGE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$181,000
-16.2%
565,225
+114.4%
0.00%
Q3 2018$216,000
-60.1%
263,600
-46.2%
0.00%
Q2 2018$541,000
+88.5%
490,100
+101.4%
0.00%
Q1 2018$287,000
-82.5%
243,400
+39.2%
0.00%
-100.0%
Q4 2017$1,638,000
-11.6%
174,800
+1.2%
0.00%0.0%
Q3 2017$1,853,000
+197.0%
172,700
+184.0%
0.00%
+100.0%
Q2 2017$624,000
+110.1%
60,800
+86.5%
0.00%
Q1 2017$297,00032,6000.00%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$24,058,00016.90%
VHCP Management II, LLC 1,933,582$19,839,0007.92%
ACUTA CAPITAL PARTNERS, LLC 1,504,612$15,437,0004.32%
Opaleye Management Inc. 130,000$1,334,0000.56%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,539,0000.26%
DAFNA Capital Management LLC 19,400$199,0000.14%
REGENTATLANTIC CAPITAL LLC 134,900$1,384,0000.13%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 14,400$148,0000.10%
TFS CAPITAL LLC 20,080$206,0000.08%
EAGLE ASSET MANAGEMENT INC 901,359$9,247,0000.06%
View complete list of EDGE THERAPEUTICS INC shareholders